Expression of transforming growth factor-β-inducible gene-h3 in normal and cyclosporine-treated rat kidney

Journal of Laboratory and Clinical Medicine

Volumn 143, Issue 3, 2004, Pages 175-183

  Sun, Bo Kyung ^b   Li, Can ^b   Lim, Sun Woo ^b   Jung, Ju Young ^b   Lee, Suk Hee ^b   Kim, In San ^b   Kim, Yong Soo ^b   Kim, Jin ^b   Bang, Byung Kee ^b   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERSTITIAL NEPHRITIS; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MEDULLA; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SALT INTAKE; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE GENE H3; UPREGULATION;

EID: 12144287397     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2003.10.014     Document Type: Article

References (33)

1. Myers BD, Sibley R, Newton L, Tomlanovich SJ, Boshkos C, Stinson E, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988;33:590-600.
2. Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, et al. Prevention of experimental cyclosporin- induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995;269:F491-9.
3. Yang CW, Kim YS, Kim J, Kim YO, Min SY, Choi EJ, et al. Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats. Exp Nephrol 1998;6:50-6.
4. Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998;53:897-908.
5. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995;6:1186-96.
6. Shihab FS, Andoh TF, Tanner AM, Noble NA, Border WA, Franceschini N, et al. Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996;49:1141-51.
7. Border WA, Noble NA. Transforming growth factor-beta in tissue fibrosis. N Engl J Med 1994;331:1286-392.
8. Sharma K, Ziyadeh FN. The transforming growth factor-beta system and the kidney. Semin Nephrol 1993;13:116-28.
9. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, et al. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 1995;270:7304-10.
10. Oreffo RO, Mundy GR, Seyedin SM, Bonewald LF. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem Biophys Res Commun 1989;158:817-23.
11. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990;346:281-4.
12. O'Connor-McCourt MD, Wakefield LM. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J Biol Chem 1987;262:14090-9.
13. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 1992;11:511-22.
14. Kim JE, Jeong HW, Nam JO, Lee BH, Choi JY, Park RW, et al. Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem 2002;277:46159-65.
15. Hashimoto K, Noshiro M, Ohno S, Kawamoto T, Satakeda H, Akagawa Y, et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. Biochim Biophys Acta 1997;1355:303-14.
16. Kim JE, Kim SJ, Lee BH, Park RW, Kim KS, Kim IS. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. J Biol Chem 2000;275:30907-15.
17. O'Brien ER, Bennett KL, Garvin MR, Zderic TW, Hinohara T, Simpson JB, et al. Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler Thromb Vasc Biol 1996;16:576-84.
18. Langham RG, Egan MK, Dowling JP, Gilbert RE, Thomson NM. Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy. Transplantation 2001;72:1826-9.
19. Rosen S, Greenfeld Z, Brezis M. Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury. Transplantation 1990;49:445-52.
20. Elzinga LW, Rosen S, Bennett WM. Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. J Am Soc Nephrol 1993;4:214-21.
21. Li C, Yang CW, Kim WY, Jung JY, Cha JH, Kim YS, et al. Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Am J Physiol Renal Physiol 2003;284:F389-98.
22. Lee EH, Seomun Y, Hwang KH, Kim JE, Kim IS, Kim JH, et al. Overexpression of the transforming growth factor-beta-inducible gene beta ig-h3 in anterior polar cataracts. Invest Ophthalmol Vis Sci 2000;41:1840-5.
23. Yang CW, Ahn HJ, Kim WY, Li C, Jung JY, Yoon SA, et al. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation 2003;75:309-15.
24. Billings PC, Whitbeck JC, Adams CS, Abrams WR, Cohen AJ, Engelsberg BN, et al. The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J Biol Chem 2002;277:28003-9.
25. Gibson MA, Kumaratilake JS, Cleary EG. Immunohistochemical and ultrastructural localization of MP78/70 (beta ig-h3) in extracellular matrix of developing and mature bovine tissues. J Histochem Cytochem 1997;45:1683-96.
26. Billings PC, Herrick DJ, Kucich U, Engelsberg BN, Abrams WR, Macarak EJ, et al. Extracellular matrix and nuclear localization of beta ig-h3 in human bladder smooth muscle and fibroblast cells. J Cell Biochem 2000;79:261-73.
27. Gilbert RE, Wilkinson-Berka JL, Johnson DW, Cox A, Soulis T, Wu LL, et al. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Kidney Int 1998;54:1052-62.
28. Shihab FS, Andoh TF, Tanner AM, Bennett WM. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis 1997;30:71-81.
29. Ling H, Li X, Jha S, Wang W, Karetskaya L, Pratt B, et al. Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J Am Soc Nephrol 2003;14:377-88.
30. Waiser J, Dell K, Bohler T, Dogu E, Gaedeke J, Budde K, et al. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Nephrol Dial Transplant 2002;17:1568-77.
31. Wolf G, Zahner G, Ziyadeh FN, Stahl RA. Cyclosporin A induces transcription of transforming growth factor beta in a cultured murine proximal tubular cell line. Exp Nephrol 1996;4:304-8.
32. Shihab FS, Yi H, Bennett WM, Andoh TF. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclo-sporine nephrotoxicity. Kidney Int 2000;58:1174-85.
33. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 1991;40:1328-34.